US BioPharmaceutical company, Merck, to make the treatment available to millions of people in mostly low- and middle-income nations.
World
U.S. drug company Merck to share license for experimental covid-19 treatment with non-profit
US BioPharmaceutical company, Merck, to make the treatment available to millions of people in mostly low- and middle-income nations.
World
More Stories
Morning News Stories: Monday July 14th, 2025
Why We Need to Decentralize Global Internet Services
Trump’s “Big Beautiful Bill” Passes the U.S. Senate